Why TP ICAP is a buy despite share-price underperformance

TP ICAP shares have remained unloved by investors for a very long time, but there is a potential catalyst that might change everything. So, what’s changed?

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Stack of one pound coins falling over

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

TP ICAP (LSE:TCAP) has not been popular among investors since the Brexit vote and the share price has fallen nearly 50% in the last 12 months due to the pandemic and the Russia-Ukraine war. However, the company has been a beneficiary of higher levels of volatility and trading activity, as seen in the company’s Q1 trading update on 11 May. TP ICAP has currently a market capitalisation of £820m, though this article will demonstrate why it is significantly undervalued and is worth buying for my portfolio.

Firstly, the business has a book value of £1.9bn and is therefore trading at a discount to its book value, i.e. the sum of all its assets minus liabilities. If we look more closely at TP ICAP’s assets, we can use a sum-of-the-parts analysis to understand the undervaluation.

  1. As of 31 December 2021, the company had £784m of cash and cash equivalents on its balance sheet, which is equivalent to 95% of the market valuation.
  2. TP ICAP recently purchased Liquidnet, a leading electronic block crossing platform, for $700m (approximately £590m at today’s exchange rate)
  3. Lastly, TP ICAP is itself a cash-generative business. The company has been free cash flow positive and has produced on average £110m free cash flow over the last three years despite a pandemic.
Year202120202019
Cash from operating activities£111m£144m£148m
Purchase of property, plant and equipment(£23m)(£35m)(£13m)
Free cash flow£88m£109m£135m
Source: TP ICAP annual reports

Potential catalyst

A US activist, Phase 2 Partners, wrote to TP ICAP earlier this year to explore strategic alternatives to unlock value for existing investors who have suffered from a dramatic share-price underperformance over the last five years. Hence, there is a potential to benefit from a large capital appreciation if the company is sold.

City analysts have assigned an average target price of £2.63, representing a near 160% upside from the current share price. As compensation for waiting until the company is sold off or a turnaround happens, TP ICAP has a dividend yield of 9%+ which is above the FTSE 100 market average and provides protection against further share-price falls.

Risks

There are numerous risks to the above thesis. Firstly, there is no guarantee that a merger or acquisition will happen so I would have to bear this risk in mind.

Secondly, there has been some criticism on the wisdom of TP ICAP’s board decisions. With hindsight, the purchase of Liquidnet did not stop the long-term decline in the share price and the board should have opted for a different approach, for example through share repurchases, which has been lacking for a company trading at a steep discount to its book value.

Conclusion

Overall, TP ICAP offers quality assets trading at a discount, a strong potential for capital appreciation due to M&A, and a dividend yield providing protection against the share price falling further.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Yuven Chetty owns shares in TP ICAP. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »